Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II (APPROACH-IS II)
APPROACH-IS II: Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II
Sponsor: KU Leuven
This observational or N/A phase trial investigates Congenital Heart Disease and is currently completed. KU Leuven leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2024 — Jul 2024 [monthly]
Completed
-
Feb 2023 — Jun 2024 [monthly]
Completed
▶ Show 5 earlier versions
-
Sep 2022 — Feb 2023 [monthly]
Completed
Status: Recruiting → Completed
-
May 2022 — Sep 2022 [monthly]
Recruiting
-
Apr 2022 — May 2022 [monthly]
Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
-
Jun 2021 — Mar 2022 [monthly]
Recruiting
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .